Shanghai Pharmaceuticals Holding Co., Ltd (SPH, SHA: 601607; HKG: 2607), a leading pharmaceutical company in China, has announced that its subsidiary, Shaphar Medical Instruments (Shanghai) Co., Ltd, has entered into a partnership with Magic Med, a Chinese firm. This strategic collaboration signifies Shaphar Med’s inaugural venture into the oncology sector. The two companies will pool their technological strengths to delve into multimodal thermophysical technology for tumor therapy. Financial specifics of the partnership were not disclosed.
The agreement encompasses a range of activities including market promotion, channel support, and commercial development, aiming to enhance their presence in the medical field.- Flcube.com
